0001437749-24-004621.txt : 20240216 0001437749-24-004621.hdr.sgml : 20240216 20240216171257 ACCESSION NUMBER: 0001437749-24-004621 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240216 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL HEALTHCARE CORP CENTRAL INDEX KEY: 0001047335 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 522057472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13489 FILM NUMBER: 24649461 BUSINESS ADDRESS: STREET 1: 100 E. VINE ST CITY: MURFREESBORO STATE: TN ZIP: 37130 BUSINESS PHONE: 6158902020 MAIL ADDRESS: STREET 1: 100 E. VINE ST CITY: MURFREESBORO STATE: TN ZIP: 37130 8-K 1 nhc20240215_8k.htm FORM 8-K nhc20240215_8k.htm
false 0001047335 0001047335 2024-02-16 2024-02-16
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 16, 2024 (February 16, 2024)
 
 
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
     
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
  
37130
(Zip Code)
 
Registrant’s telephone number, including area code: (615) 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on February 16, 2024, announcing its December 31, 2023 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)         Exhibits.
 
Exhibit No.
Description of Exhibit
99.1
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         February 16, 2024
 
 
NATIONAL HEALTHCARE CORPORATION
  
       
       
 
By:
/s/ 
Brian F. Kidd
  
 
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
  
 
 
 EX-99.1 2 ex_627236.htm EXHIBIT 99.1 ex_627236.htm

 

Exhibit 99.1

 

a01.jpg

 

 

For release: February 16, 2024

Contact: Brian F. Kidd, SVP/CFO

Phone: (615) 890-2020

 

NHC Reports 2023 Year End Earnings

 

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2023 totaled $1,141,544,000 compared to $1,085,738,000 for the year ended December 31, 2022, an increase of 5.1%. Excluding the government stimulus income and the seven skilled nursing facilities in Massachusetts and New Hampshire in which we ceased operations in September 2022, same-facility net operating revenues increased 11.3% for the year ended December 31, 2023 compared to the 2022 year.

For the year ended December 31, 2023, the reported GAAP net income attributable to NHC was $66,798,000 compared to $22,445,000 for the 2022 year. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the year ended December 31, 2023 was $54,934,000 compared to $37,323,000 for the 2022 year (*), an increase of 47.2%. GAAP diluted earnings per share were $4.34 compared to $1.45 for the years ended December 31, 2023 and 2022, respectively. Adjusted diluted earnings per share were $3.55 compared to $2.42 for the years ended December 31, 2023 and 2022, respectively (*).

For the quarter ended December 31, 2023, the reported GAAP net income attributable to NHC was $28,406,000 compared to $6,353,000 for the same period in 2022. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended December 31, 2023 was $15,955,000 compared to $11,046,000 for the same period in 2022 (*), an increase of 44.4%. The GAAP diluted earnings per share were $1.83 compared to $0.41 for the quarters ended December 31, 2023 and 2022, respectively. Adjusted diluted earnings per share were $1.03 compared to $0.72 for the quarters ended December 31, 2023 and 2022, respectively (*).

 

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

 

 

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,732 beds. NHC affiliates also operate 26 assisted living communities with 1,501 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

 

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

 

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

 

-more-

 

 
 

 

Page 2

 

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

 

   

Three Months Ended

    

Years Ended

  
   

December 31

    

December 31

  
   

2023

    

2022

    

2023

    

2022

  

Revenues and grant income:

                                

Net patient revenues

   $ 282,997     $ 252,424     $ 1,087,614     $ 1,029,085  

Other revenues

     17,917       11,612       53,930       45,196  

Government stimulus income

     -       517       -       11,457  

Net operating revenues and grant income

     300,914       264,553       1,141,544       1,085,738  
                                 

Costs and expenses:

                                

Salaries, wages and benefits

     186,562       167,341       712,344       686,169  

Other operating

     70,970       67,365       288,183       285,644  

Facility rent

     11,438       10,207       41,525       40,977  

Depreciation and amortization

     11,768       10,478       42,034       40,489  

Interest

     56       112       324       563  

Total costs and expenses

     280,794       255,503       1,084,410       1,053,842  
                                 

Income from operations

     20,120       9,050       57,134       31,896  
                                 

Non-operating income

     4,544       2,690       16,660       11,141  

Unrealized gains/(losses) on marketable equity securities

     12,001       (4,327 )     14,944       (15,806 )
                                 

Income before income taxes

     36,665       7,413       88,738       27,231  

Income tax provision

     (8,700 )     (1,839 )     (23,450 )     (7,254 )

Net income

     27,965       5,574       65,288       19,977  
                                 

Net loss attributable to noncontrolling interest

     441       779       1,510       2,468  
                                 

Net income attributable to National HealthCare Corporation

   $ 28,406     $ 6,353     $ 66,798     $ 22,445  
                                 

Net income per common share

                                

Basic

   $ 1.86     $ 0.41     $ 4.36     $ 1.46  

Diluted

   $ 1.83     $ 0.41     $ 4.34     $ 1.45  
                                 

Weighted average common shares outstanding

                                

Basic

     15,306,253       15,326,680       15,310,142       15,410,222  

Diluted

     15,486,573       15,358,488       15,377,343       15,447,211  
                                 

Dividends declared per common share

   $ 0.59     $ 0.57     $ 2.34     $ 2.26  

 

Balance Sheet Data

  

Dec 31,

    

Dec 31,

  

(in thousands)

  

2023

    

2022

  
                 

Cash, cash equivalents and marketable securities

   $ 223,620     $ 182,589  

Restricted cash, cash equivalents and marketable securities

     167,971       158,067  

Current assets

     406,235       353,932  

Property and equipment, net

     493,329       506,532  

Total assets

     1,310,796       1,275,450  

Current liabilities

     214,476       197,887  

Stockholders' equity

     910,480       877,514  

 

-more-

 

 
 

 

Page 3

 

Selected Operating Statistics

 

   

Three Months Ended

    

Years Ended

  
   

December 31

    

December 31

  
   

2023

    

2022

    

2023

    

2022

  

Skilled Nursing Per Diems:

                                

Medicare

   $ 579.84     $ 544.11     $ 559.07     $ 541.23  

Managed Care

     478.51       482.99       464.89       439.07  

Medicaid

     268.58       236.86       253.95       232.22  

Private Pay and Other

     290.85       265.55       282.14       267.50  

Average Skilled Nursing Per Diem

   $ 337.57     $ 310.82     $ 324.53     $ 304.04

(1)
                                 

Skilled Nursing Patient Days:

                                

Medicare

     79,025       82,965       318,253       341,926  

Managed Care

     62,031       51,003       242,023       214,826  

Medicaid

     288,538       284,208       1,140,612       1,204,139  

Private Pay and Other

     170,916       157,174       663,195       646,651  

Total Skilled Nursing Patient Days

     600,510       575,350       2,364,083       2,407,542

(1)

 

(1) For the year ended December 31, 2022, the skilled nursing per diems and patient days listed above include the seven skilled nursing facilities that were located in Massachusetts and New Hampshire through August 31, 2022.  NHC exited these seven skilled nursing facilities on September 1, 2022. For the years ended December 31, 2022, the exited Massachusetts and New Hampshire skilled nursing facilities had an average skilled nursing per diem of $294.55 and 140,105 total patient days.

 

 

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

 

   

Three Months Ended

    

Years Ended

  
   

December 31

    

December 31

  
   

2023

    

2022

    

2023

    

2022

  
                                 

Net income attributable to National Healthcare Corporation

   $ 28,406     $ 6,353     $ 66,798     $ 22,445  

Non-GAAP adjustments

                                

Unrealized (gains)/losses on marketable equity securities

     (12,001 )     4,327       (14,944 )     15,806  

Gain on sale of property and equipment

     (6,230 )     -       (6,230 )     -  

Operating results for newly opened operations not at full capacity (2)

     742       1,383       2,359       5,416  

Impairment/(recovery) of assets

     -       -       -       (3,728 )

Stock-based compensation expense

     663       632       2,782       2,612  

Income tax (benefit)/provision on non-GAAP adjustments

     4,375       (1,649 )     4,169       (5,228 )

Non-GAAP Net income

   $ 15,955     $ 11,046     $ 54,934     $ 37,323  
                                 

GAAP diluted earnings per share

   $ 1.83     $ 0.41     $ 4.34     $ 1.45  

Non-GAAP adjustments

                                

Unrealized (gains)/losses on marketable equity securities

     (0.57 )     0.21       (0.72 )     0.76  

Gain on sale of property and equipment

     (0.30 )             (0.30 )        

Operating results for newly opened operations not at full capacity (2)

     0.04       0.07       0.10       0.26  

Impairment/(recovery) of assets

     -               -       (0.18 )

Stock-based compensation expense

     0.03       0.03       0.13       0.13  

Non-GAAP diluted earnings per share

   $ 1.03     $ 0.72     $ 3.55     $ 2.42  

 

(2) The newly opened operations not at full capacity for the 2023 periods presented consisted of operations opened from 2021 through 2023.  This consisted of two behavioral health hospitals, two homecare agencies, and two hospice agencies.  The newly opened operations for the 2022 periods presented consisted of operations opened from 2020 through 2022.  This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency.

 

###

 

 

 

 

 
 EX-101.SCH 3 nhc-20240216.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 nhc-20240216_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 nhc-20240216_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 nhc-20240216_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 a01.jpg begin 644 a01.jpg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htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Feb. 16, 2024
Document Information [Line Items]  
Entity, Registrant Name NATIONAL HEALTHCARE CORPORATION
Document, Type 8-K
Document, Period End Date Feb. 16, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-13489
Entity, Tax Identification Number 52-2057472
Entity, Address, Address Line One 100 E. Vine Street
Entity, Address, City or Town Murfreesboro
Entity, Address, State or Province TN
Entity, Address, Postal Zip Code 37130
City Area Code 615
Local Phone Number 890-2020
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol NHC
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001047335
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( )N)4%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " ";B5!8YVA!3^X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M3L,P#(9?!>7>NLU@AZCK98@32$A, G&+'&^+:)HH,6KW]K1AZX3@ 3C&_O/Y ML^0&@T(?Z3GZ0)$MI9O1=7U2&#;BR!P40,(C.9W**=%/S;V/3O/TC <(&C_T M@4!6U1HY!M+*2MT4EBWJ]DU+54MW)]]GUA]]5V'EC]_8? M&U\$VP9^W47[!5!+ P04 " ";B5!8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M )N)4%BV9[Y_1P0 *(0 8 >&PO=V]R:W-H965T&UL ME9AM;^HV%,>_BI5)TR:US0./[0")4KJBVU($[%YMTUZ8Q &K29S93H%OO^, M"=,-)]PWY,GGGU^.C_^VZ6V%_% ;QC39Q5&B^M9&Z_3!MI6_83%5=R)E"3P) MA8RIADNYME4J&0WRH#BR/<=IVS'EB37HY?=FZ.B3@+:'@7 KQC@)=S'UZ44SY130<]*;9$FM:@9D[R3\VC M 8XGIE<66L)3#G%Z\"3\#)*LR3 )R#C17._))#GT-F2M9VMXB6EJ^T?!QX.@ M=T'PF:WNB-N^(9[C-?\?;@-; >@5@%ZNUZ@#/*,B?[]"*S+1+%;_5"$>))O5 MDJ;0'U1*?=:WH)(5DY_,&OS\D]MV?D. &P5P U,?'))X0^9LS966%-"G-&95 MF+C0=+B@$A=7?QHCB)T"L7,5XC./&)EF\8K)*A)+MGR;CVGU6EV/(3OON"[OXIO& 0P^E5Q M0G)3>4\J.Q*7=!V'C._(5R, ]\&,$4[7*;W9^3'2D;%G*+NEV%9;,Z[WELD0 MX-1*2($!GDT>[H\!%@-C)L4G3_S*7-:(+C%K<\MYPT5=_GNVF5":1N0OGEX< MKC62C8[;<#"XY MYLF:O$%]2TZC2AY[@[+R4-3(DM]O%*5!98C<#T982!E*[NX09\2@H9[_P- M3=;LX@*V1FCZYP);X7AG>X#KO'P<,[DV.?H=)/3&>$1*D\K>JU&LJRBOM'(/ M=^(AU'F0U_IS1->5*+A +4IIYA[NPZ!Y*(0^79A];?&WQ. _4$L#!!0 ( )N)4%B?H!OPL0( .(, - M>&PO9KEMWDOSAR+DCO9*ZW="C<\W[ M)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3 M;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@ M:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_& M%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V M_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUS MS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D M^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>P MSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0 M_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^& M<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8 M[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( )N)4%B7BKL< MP !," + 7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$ M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G7&BN"^) M]NK+NY *W3"W\RQ+50/>I"MJ(-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0> M09:'[L#TA(XA+@W#"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P M4:V%&@/8-SF0!)?DJG547>EYIM[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;! M4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%0 M2P,$% @ FXE06&60>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6% M3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#W MR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L? ME.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH9 M0]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTC MR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_ M/[&\UDX:?^:+X3]>?P%02P$"% ,4 " ";B5!8!T%-8H$ "Q $ M @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( )N) M4%CG:$%/[@ "L" 1 " :\ !D;V-0&UL4$L! A0#% @ FXE06+9GOG]' M! HA !@ ("!#0@ 'AL+W=O7!E&UL4$L%!@ ) D /@( .L3 $! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.nhc.com/20240216/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports nhc-20240216.xsd nhc-20240216_def.xml nhc-20240216_lab.xml nhc-20240216_pre.xml nhc20240215_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "nhc20240215_8k.htm": { "nsprefix": "nhc", "nsuri": "http://www.nhc.com/20240216", "dts": { "schema": { "local": [ "nhc-20240216.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "nhc-20240216_def.xml" ] }, "labelLink": { "local": [ "nhc-20240216_lab.xml" ] }, "presentationLink": { "local": [ "nhc-20240216_pre.xml" ] }, "inline": { "local": [ "nhc20240215_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.nhc.com/20240216/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nhc20240215_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nhc20240215_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.nhc.com/20240216/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-24-004621-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-004621-xbrl.zip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end XML 18 nhc20240215_8k_htm.xml IDEA: XBRL DOCUMENT 0001047335 2024-02-16 2024-02-16 false 0001047335 8-K 2024-02-16 NATIONAL HEALTHCARE CORPORATION DE 001-13489 52-2057472 100 E. Vine Street Murfreesboro TN 37130 615 890-2020 false false false false Common Stock NHC NYSE false